Open an account

Nature's Sunshine Products

NATR · NASDAQ

$12.71+$0.16 (+1.27%)TodayMarket closed ·
Prev close $12.55

About NATR

Nature's Sunshine Products, Inc. engages in the manufacture and sale of nutritional and personal care products. The company is headquartered in Lehi, Utah and currently employs 806 full-time employees. The company went IPO on 2009-06-25. The firm sells its products to a sales force of independent consultants who use the products themselves or resell them to consumers. The firm has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The firm's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. The company purchases herbs and other raw materials in bulk.

Employees
806
Headquarters
Lehi, Utah
Listed
Jun 25, 2009
Sector
Consumer Staples
Industry
Personal Care Products
Website
naturessunshine.com

NATR key statistics

Market cap
223.64M
Price-earnings ratio
12.43
Dividend yield
—
Average volume
103.42K
Volume
68.52K
Open price
$12.56
High today
$12.91
Low today
$12.51
52 Week high
$28.14
52 Week low
$12.00

Nature's Sunshine Products (NATR) at a glance

Nature's Sunshine Products (NATR) last traded at $12.71, with a market cap of 223.64M and a price-to-earnings ratio of 12.43.

Today the stock has traded between $12.51 and $12.91. The current price is 1.6% above the day's low and 1.5% below its high.

Volume so far is 68.52K shares, below the average of 103.42K shares a day.

Over the past year Nature's Sunshine Products has ranged from $12.00 to $28.14, and now sits 4% of the way up that range.

Nature's Sunshine Products met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.21 per share against an estimate of $0.2754.

The average analyst price target is $31.11, 144.8% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $31.11
Low
$25.25
Now
$12.71
High
$37.80

NATR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 71.7% on average.

  1. Q3 FY24: reported $0.23 per share against an estimate of $0.1428
  2. Q4 FY24: reported -$0.02 per share against an estimate of $0.204
  3. Q1 FY25: reported $0.25 per share against an estimate of $0.1683
  4. Q2 FY25: reported $0.35 per share against an estimate of $0.1632
  5. Q3 FY25: reported $0.36 per share against an estimate of $0.1632
  6. Q4 FY25: reported $0.30 per share against an estimate of $0.1938
  7. Q1 FY26: reported $0.30 per share against an estimate of $0.2295
  8. Q2 FY26: reported $0.21 per share against an estimate of $0.2754

NATR news

  • Natures Sunshine Products's Earnings: A Preview

  • Press releasePRNewswire

    Capital Rotation: Why Smart Money is Chasing Functional Wellness

  • Earnings Scheduled For November 6, 2025

  • Press releaseGlobe Newswire

    Nature's Sunshine Appoints Katie A. May to Board of Directors

  • Avi Kapoor

    Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket

Similar companies

Companies in the same industry as Nature's Sunshine Products

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.